Bingyang Hu

659 total citations
19 papers, 362 citations indexed

About

Bingyang Hu is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Bingyang Hu has authored 19 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 9 papers in Hepatology. Recurrent topics in Bingyang Hu's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Bingyang Hu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Bingyang Hu collaborates with scholars based in China, United States and Philippines. Bingyang Hu's co-authors include Tao Wan, Jiahong Dong, Shichun Lu, Hongguang Wang, Honggang Nie, Shuting Xu, Wen Ma, Yu Bai, Huwei Liu and Zhanbo Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Bingyang Hu

17 papers receiving 360 citations

Peers

Bingyang Hu

ONCOL

SURGE

PRM

HEPAT

Hong-Gang Qian China

Bashar Zeidan United Kingdom

Marc‐André Reymond Germany

Hisashi Kosaka Japan

Marcello Spampinato Italy

Yoshihiro Noda Japan

Jung Kyong Shin South Korea

Mehmet Akif Türkoğlu Türkiye

Junichi Mazaki Japan

Haruaki Hino Japan

Hong-Gang Qian China

Bingyang Hu

186 ×0.9

ONCOL

133 ×0.8

SURGE

107 ×1.0

PRM

43 ×0.5

HEPAT

113 ×1.6

Citations per year, relative to Bingyang Hu Bingyang Hu (= 1×) peers Hong-Gang Qian

Countries citing papers authored by Bingyang Hu

Since Specialization

Citations

This map shows the geographic impact of Bingyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyang Hu more than expected).

Fields of papers citing papers by Bingyang Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyang Hu. The network helps show where Bingyang Hu may publish in the future.

Co-authorship network of co-authors of Bingyang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyang Hu. A scholar is included among the top collaborators of Bingyang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyang Hu. Bingyang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Gao, Biao, Yafei Wang, Haowen Tang, et al.. (2025). NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma. Advanced Science. 12(46). e11152–e11152.

Hu, Bingyang, Wenzhi Zhang, Changsheng Zhang, et al.. (2023). CCNI2 promotes pancreatic cancer through PI3K/AKT signaling pathway. SHILAP Revista de lepidopterología. 24(2). 323–336. 1 indexed citations

Tang, Haowen, Bingyang Hu, Wenwen Zhang, et al.. (2023). Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. HPB. 25(7). 775–787. 11 indexed citations

Zhang, Ze, Junfeng Li, Bingyang Hu, et al.. (2023). Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma. World Journal of Surgical Oncology. 21(1). 53–53. 6 indexed citations

Pan, Yingwei, Li Yang, Jun Han, et al.. (2023). Factors influencing the prognosis patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma undergoing salvage surgery after conversion therapy. Translational Cancer Research. 12(7). 1852–1862. 4 indexed citations

Tang, Haowen, Wenwen Zhang, Bingyang Hu, et al.. (2023). Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors. BMC Surgery. 23(1). 384–384. 2 indexed citations

Zhang, Ze, Wenwen Zhang, Yafei Wang, et al.. (2022). Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 10. 792676–792676. 27 indexed citations

Zhang, Wenwen, Bingyang Hu, Yafei Wang, et al.. (2022). Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatology International. 17(2). 393–405. 4 indexed citations

Zhang, Ze, Jin Shang, Bingyang Hu, et al.. (2022). Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature. Frontiers in Immunology. 13. 836576–836576. 8 indexed citations

10.

Zhang, Ze, Wen‐Wen Zhang, Hongguang Wang, et al.. (2021). Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report. Frontiers in Immunology. 12. 744571–744571. 18 indexed citations

11.

Zhang, Wenwen, Shichun Lu, Bingyang Hu, et al.. (2021). PD-1 inhibitor combined with lenvatinib for unresectable liver cancer as the conversion therapy: An open-label, non-randomized, phase IV study.. Journal of Clinical Oncology. 39(15_suppl). e16173–e16173. 11 indexed citations

12.

Zhang, Wenwen, Bingyang Hu, Jun Han, et al.. (2021). Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients. Frontiers in Oncology. 11. 747950–747950. 47 indexed citations

13.

Liu, Jun, Junning Cao, Guan Wang, et al.. (2021). Abstract 944: Analysis of efficacy of receptor tyrosine kinase and immune checkpoint inhibitors and insights to potential combinatorial treatment strategies in cholangiocarcinomas. Cancer Research. 81(13_Supplement). 944–944.

14.

Li, Yu, Hongguang Wang, Ying Luo, et al.. (2019). Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade. Journal for ImmunoTherapy of Cancer. 7(1). 31 indexed citations

15.

Liu, Bing, Tian Liu, Ming Su, et al.. (2019). Improving the Surgical Effect for Primary Liver Cancer with Intraoperative Fluorescence Navigation Compared with Intraoperative Ultrasound. Medical Science Monitor. 25. 3406–3416. 14 indexed citations

16.

He, Ping, et al.. (2018). Retrospective study on the effects of the prognosis of patients treated with extracorporeal membrane oxygenation combined with continuous renal replacement therapy. Annals of Translational Medicine. 6(23). 455–455. 15 indexed citations

17.

Ma, Wen, Shuting Xu, Honggang Nie, et al.. (2018). Bifunctional cleavable probes for in situ multiplexed glycan detection and imaging using mass spectrometry. Chemical Science. 10(8). 2320–2325. 50 indexed citations

18.

Hu, Bingyang, et al.. (2016). Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy. World Journal of Gastroenterology. 22(34). 7797–7797. 111 indexed citations

19.

Hu, Bingyang. (2015). Application of single-layer mucosa-to-mucosa pancreaticojejunal anastomosis in pancreaticoduodenectomy. World Journal of Gastrointestinal Surgery. 7(11). 335–335. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact